Stockscreener 앱 받기
7.925
2.39%
0.185
시간 외 거래:
8.08
0.155
+1.96%
전일 마감가:
$7.74
열려 있는:
$8.03
하루 거래량:
1.38M
Relative Volume:
0.99
시가총액:
$703.77M
수익:
$73.48M
순이익/손실:
$-108.30M
주가수익비율:
-3.5222
EPS:
-2.25
순현금흐름:
$-67.17M
1주 성능:
-14.60%
1개월 성능:
+4.00%
6개월 성능:
+21.36%
1년 성능:
+122.61%
1일 변동 폭
$7.80
$8.38
1주일 범위
$7.68
$9.39
52주 변동 폭
$2.8262
$11.40
Personalis Inc Stock (PSNL) Company Profile
명칭
Personalis Inc
전화
650-752-1300
주소
6600 DUMBARTON CIRCLE, FREMONT, CA
PSNL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
7.925 | 687.35M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
562.39 | 211.36B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
224.35 | 157.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
697.10 | 55.54B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
136.90 | 38.68B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.52 | 37.71B | 15.90B | 1.28B | 2.21B | 7.2842 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-05-15 | 개시 | Guggenheim | Buy |
| 2025-03-17 | 개시 | Craig Hallum | Buy |
| 2023-02-06 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | 다운그레이드 | Needham | Buy → Hold |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-20 | 재확인 | Needham | Buy |
| 2021-05-06 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-28 | 개시 | Truist | Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-12 | 재확인 | Needham | Buy |
| 2020-11-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-10-19 | 개시 | Citigroup | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-08-27 | 개시 | H.C. Wainwright | Buy |
| 2020-08-18 | 개시 | Needham | Buy |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 개시 | BofA/Merrill | Neutral |
| 2019-07-15 | 개시 | Cowen | Outperform |
| 2019-07-15 | 개시 | Morgan Stanley | Overweight |
| 2019-07-15 | 개시 | Oppenheimer | Outperform |
모두보기
Personalis Inc 주식(PSNL)의 최신 뉴스
Will Personalis Inc. (04X) stock split increase liquidityJuly 2025 Price Swings & Daily Price Action Insights - Улправда
How Personalis Inc. stock reacts to bond yieldsJuly 2025 Opening Moves & Fast Gain Swing Alerts - Улправда
Personalis study shows cancer blood test predicts immunotherapy outcomes By Investing.com - Investing.com Nigeria
Personalis study shows cancer blood test predicts immunotherapy outcomes - Investing.com
Personalis announces new publication applying ultrasensitive ctDNA testing - marketscreener.com
Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors - Business Wire
Personalis (NASDAQ:PSNL) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Personalis (NASDAQ:PSNL) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer - Business Wire
What AI ML Trends Might Elevate Afcons Infrastructure Limiteds Stock ProspectsDividend Yield Trends & Free Dynamic Investment Techniques - earlytimes.in
Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds - Yahoo Finance
Personalis, Inc. $PSNL Shares Purchased by Blue Water Life Science Advisors LP - MarketBeat
Personalis, Inc. (NASDAQ:PSNL) Stocks Shoot Up 38% But Its P/S Still Looks Reasonable - 富途牛牛
Personalis (NASDAQ:PSNL) Stock Price Down 4.8%What's Next? - MarketBeat
Personalis Outpaces The Market With Cancer Test Breakthroughs - Finimize
Personalis (NASDAQ:PSNL) Cut to Sell at Wall Street Zen - MarketBeat
Is Personalis Inc. (04X) stock undervalued by metricsEarnings Miss & Short-Term High Return Strategies - Newser
Geode Capital Management LLC Buys 851,422 Shares of Personalis, Inc. $PSNL - MarketBeat
Will Personalis Inc. (04X) stock maintain strong growthWeekly Volume Report & Growth Focused Investment Plans - Newser
Will Personalis Inc. (04X) stock beat Nasdaq index returns2025 Short Interest & Real-Time Volume Spike Alerts - Newser
Will Personalis Inc. (04X) stock outperform Dow JonesMarket Risk Summary & Fast Moving Market Watchlists - Newser
How Personalis Inc. stock performs during Fed tightening cycles2025 Growth vs Value & Weekly Chart Analysis and Trade Guides - Newser
Will Personalis Inc. stock reach Wall Street targetsInsider Selling & Free Expert Verified Stock Movement Alerts - Newser
Personalis (PSNL) Rating Maintained and Price Target Raised by M - GuruFocus
Personalis (NASDAQ:PSNL) Shares Gap Down After Insider Selling - MarketBeat
Personalis, Inc. (NASDAQ:PSNL) Q2 2025 Earnings Call Transcript - MSN
Morgan Stanley Raises Price Target on Personalis to $11 From $9, Keeps Equalweight Rating - marketscreener.com
Piper Sandler Healthcare Conference - MarketScreener
Personalis, Inc. (NASDAQ:PSNL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Personalis Announces $100M Stock Offering Amendment - The Globe and Mail
Insider Selling: Personalis (NASDAQ:PSNL) CFO Sells 103,668 Shares of Stock - MarketBeat
Personalis files prospectus supplement for up to $100 million stock offering - Investing.com Nigeria
Personalis files prospectus supplement for up to $100 million stock offering By Investing.com - Investing.com South Africa
Personalis, Inc. Announces $100 Million Stock Offering - TradingView
Personalis CFO and COO Aaron Tachibana Sells Over 100K Shares - TradingView
COO Tachibana Sells 103,668 ($1.1M) Of Personalis Inc [PSNL] - TradingView
Insiders Of Personalis Make A Tidy Sum Selling At US$7.14 - simplywall.st
Personalis Stock: A Growth Inflection Is Imminent (NASDAQ:PSNL) - Seeking Alpha
Personalis (NASDAQ:PSNL) Hits New 12-Month HighHere's What Happened - MarketBeat
Personalis Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
COO Tachibana Files To Sell 103,668 Of Personalis Inc [PSNL] - TradingView
Personalis says CMS revises reimbursement rate for Personal test for post-treatment surveillance of cancers - marketscreener.com
Personalis Says CMS Revises Reimbursement Rate For Personal Test For Post-Treatment Surveillance Of Cancers - TradingView
Personalis receives updated Medicare reimbursement rates for cancer monitoring tests - Investing.com India
Personalis, Inc. Announces Revised Medicare Reimbursement Rates - TradingView
[8-K] Personalis, Inc. Reports Material Event | PSNL SEC FilingForm 8-K - Stock Titan
Personalis Inc (PSNL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.73%
1.48%
자본화:
|
볼륨(24시간):